Novel system for the BCS class II drug molecules with poor oral bioavailability.
Systematic optimized Novel S-SNEOFs for enhanced bioavailability of lopinavir.
Safe delivery system of lopinavir for the effective accessibility to the GALT.
Efficacious therapy for the eradication of the HIV loads in sanctuary sites.